Corpus Intelligence IC Memo — COMMUNITY HOSPITAL OF ANACONDA 2026-04-26 08:08 UTC
IC Memo — COMMUNITY HOSPITAL OF ANACONDA
Investment Committee Memorandum | MT | 25 beds | Grade C | EBITDA uplift $6.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COMMUNITY HOSPITAL OF ANACONDA

CCN 271335 | DEER LODGE, MT | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COMMUNITY HOSPITAL OF ANACONDA is a 25-bed suburban community hospital in DEER LODGE, MT with $89.0M in net patient revenue and a 1.3% operating margin. The hospital serves a payer mix of 49.3% Medicare, 11.7% Medicaid, and 39.1% commercial.

Thesis: Turnaround. Our ML models identify $6.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.3% to 8.6% (+736bps).

Net Revenue HCRIS$89.0M
Current EBITDA COMPUTED$1.1M
Operating Margin COMPUTED1.3%
Occupancy HCRIS44.9%
Revenue / Bed COMPUTED$3.6M
Net-to-Gross HCRIS57.5%
Distress Probability ML51.5%

2. Market Context & Competitive Position

66
MT Hospitals
-9.6%
State Median Margin
48
Comparable Hospitals

MT has 66 Medicare-certified hospitals with a median operating margin of -9.6%. The target's margin of 1.3% places it above the state median. Among 48 size-comparable peers (12-50 beds), the median margin is -9.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 48 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COMMUNITY HOSPITAL OF ANACONDA (Target)MT25$89.0M1.3%
GREAT FALLS CLINIC MEDICAL CENMT20$132.1M21.0%
MARCUS DALY MEMORIAL HOSPITALMT25$107.6M-1.3%
LOGAN HEALTH WHITEFISHMT25$101.8M13.8%
SIDNEY HEALTH CENTERMT25$95.2M-6.3%
NORTHERN MONTANA HOSPITALMT49$93.3M-4.7%
LIVINGSTON HEALTHCAREMT25$72.6M-7.1%
HOLY ROSARY HEALTHCAREMT25$67.3M1.3%
HEALTHCENTER NORTHWESTMT17$67.2M24.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.9M+210bp18mo
Cost to Collect4.5%2.5%$1.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$57K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.9M
Cost to Collect
$1.8M
Denial Rate Reduction
$1.8M
A/R Days Reduction
$1.1M
Clean Claim Rate
$57K
Total EBITDA Uplift$6.5M
Current EBITDA$1.1M
+ RCM Uplift+$6.5M
Pro Forma EBITDA$7.7M
Current Margin1.3%
Pro Forma Margin8.6%
WC Released (1x)$3.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.7M$72.8M42.50x111.7%
Base (11x exit)10.0x11.0x$1.7M$80.7M47.08x116.1%
Bull Case9.0x11.0x$1.5M$102.8M66.68x131.6%
Bull (12x exit)9.0x12.0x$1.5M$112.6M73.04x135.9%
Bear Case11.0x10.0x$1.9M$39.5M20.97x83.8%
Bear (11x exit)11.0x11.0x$1.9M$44.1M23.39x87.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 51.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 48 hospitals with 12-50 beds
  • Same-state prioritization (n=49)
  • Comp margins: P25=-20.8% / P50=-9.3% / P75=-2.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.